Mid Sweden University

miun.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Assessing salivary matrix metalloproteinase-8 in prostate cancer patients undergoing androgen deprivation therapy
Mid Sweden University, Faculty of Human Sciences, Department of Health Sciences (HOV). (Swedish Winter Sports Research Centre)
2022 (English)In: Clinical and Experimental Dental Research, E-ISSN 2057-4347, Vol. 8, no 5, p. 1277-1283Article in journal (Refereed) Published
Abstract [en]

Introduction: Matrix metalloproteinase-8 (MMP-8) is considered as one of the most promising diagnostic markers for periodontal disease. Androgen deprivation therapy (ADT) has been correlated with impaired collagen synthesis and an increase in periodontal tissue susceptibility to pathogenic microorganisms. Objective: This study aims to investigate the impact of ADT on salivary MMP-8 level and periodontal parameters, which might be useful in monitoring periodontal disease in prostate cancer patients undergoing ADT. Materials and Methods: A total of 88 subjects were selected and were divided into two groups: Group I included n = 78 PC patients who have been undergoing ADT); Group II included n = 10 healthy individuals. Periodontal parameters such as plaque index (PI), gingival index (GI), periodontal probing depth (PPD), and clinical attachment level (CAL) were examined. The salivary MMP-8 level was estimated by using the sandwich enzyme-linked immunosorbent assay method. Results: Significant differences in mean salivary MMP-8 level were found between PC patients undergoing ADT and healthy individuals. Salivary MMP-8 levels of all individuals were positively correlated with GI, PI, PPD, and CAL. Salivary MMP-8 can distinguish between periodontitis and healthy individuals with an accuracy of about 80%. Conclusion: Salivary MMP-8 levels were found to be higher in prostate cancer patients undergoing ADT compared to healthy individuals. 

Place, publisher, year, edition, pages
2022. Vol. 8, no 5, p. 1277-1283
Keywords [en]
androgen antagonists, biomarker, MMP-8, periodontal diseases, saliva
National Category
Clinical Medicine Cancer and Oncology
Identifiers
URN: urn:nbn:se:miun:diva-45731DOI: 10.1002/cre2.624ISI: 000818553000001Scopus ID: 2-s2.0-85133055284OAI: oai:DiVA.org:miun-45731DiVA, id: diva2:1685140
Available from: 2022-08-01 Created: 2022-08-01 Last updated: 2023-06-22Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textScopus

Authority records

Lee, Ka Yiu

Search in DiVA

By author/editor
Lee, Ka Yiu
By organisation
Department of Health Sciences (HOV)
In the same journal
Clinical and Experimental Dental Research
Clinical MedicineCancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 64 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf